Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today

By Admin

03 Jun, 2025

If you are wondering which stocks to watch out for, here’s a quick roundup of companies making headlines – from fundraising moves and strategic deals to regulatory approvals and global partnerships. Let’s take a look at the stocks that are in focus today.

Market Recap

Indian equity benchmarks ended on a muted note on June 2, 2025, amid intraday volatility. The Sensex slipped 77.26 points (0.09%) to close at 81,373.75, while the Nifty shed 34.10 points (0.14%), settling at 24,716.60. Amid a cautious market sentiment, several companies are drawing investor attention through notable announcements and developments.

Top 7 Stocks to Watch on June 3, 2025

1. Grasim Industries

The Aditya Birla Group’s flagship firm, Grasim Industries, is set to tap into the bond market. The company's Finance Committee has approved the issuance of non-convertible debentures (NCDs) worth up to Rs 1,000 crore. These unsecured, listed, and redeemable NCDs are priced at Rs 1,00,000 each and will be privately placed in one or more tranches. This move aims to strengthen the company’s financial flexibility and support its growth plans.

2. HCL Technologies

HCL Technologies has entered a global strategic partnership with UiPath, a leader in agentic automation. This collaboration aims to revolutionize enterprise operations by integrating intelligent, autonomous process automation across HR, finance, operations, and IT workflows. The technology involves advanced bots capable of learning and decision-making with minimal human input   paving the way for a transformative shift in how businesses operate.

3. Torrent Power

Torrent Power has secured a long-term LNG supply agreement with BP Singapore, the energy division of oil giant BP. The deal ensures the supply of up to 0.41 million tonnes per annum (MTPA) of LNG from 2027 to 2036. This will power Torrent’s 2,730 MW gas-based power plants, ensuring energy stability and cost-effective fuel sourcing for the long term.

4. Biocon

Biocon is in the spotlight after receiving regulatory approval in India for its version of Liraglutide, the key ingredient in Novo Nordisk’s diabetes drug Victoza. This injectable treatment is used for managing Type 2 diabetes in adults and children (10+ years). Biocon Pharma, the wholly-owned subsidiary, has also received clearance for the pre-filled pens and cartridges, marking a significant milestone in its diabetes care portfolio.

5. Glenmark Pharma

Ichnos Glenmark Innovation (IGI), the biotech joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, has released positive results from a global Phase 1 study. The focus of this trial is on a treatment for relapsed or refractory multiple myeloma, a blood cancer that affects the bone marrow. These early-stage results are a promising step forward in the company’s oncology pipeline.

6. UGRO Capital

NBFC UGRO Capital, focused on fintech-driven lending, has finalized terms for its Rs 400 crore rights issue. Shares will be offered to existing public shareholders at Rs 162 per share. This comes on the heels of its earlier announcement to raise Rs 915 crore via compulsory convertible debentures (CCDs). The fundraising aims to enhance capital adequacy and support lending growth.

7. MAN Industries

Mumbai-headquartered MAN Industries, a manufacturer of pipes for the oil and gas sector, is planning to raise up to Rs 300 crore. The company will issue 12.19 lakh convertible warrants to Man Finance (a promoter group entity) and 79.26 lakh equity shares to non-promoters, each priced at Rs 328. The infusion will be used to bolster capacity and meet future infrastructure demands.

Conclusion

While broader markets remain cautious, these seven companies stand out with significant corporate developments. From capital raising efforts and innovative partnerships to drug approvals and long-term energy deals, these moves could have meaningful impacts on stock performance. Traders and investors would do well to keep a close eye on these stocks as the week unfolds.